CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Peri-articular tranexamic acid +1 moredrug
Likely dose
Peri-articular tranexamic acid 750 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02829346
NCT02829346Phase 2Completed
CompareCT.gov

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial

Thammasat University·interventional·Posted Jul 12, 2016·Updated Jul 12, 2016

In Brief

A Phase 2 clinical trial evaluating Peri-articular tranexamic acid and Intravenous tranexamic acid for Osteoarthritis, Knee. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study evaluates the peri-articular tranexamic acid injection in total knee arthroplasty which is an alternative route of administration for blood loss reduction. Half of participants will receive intravenous tranexamic acid injection, while the other half will receive peri-articular tranexamic acid injection during total knee arthroplasty.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesThailand
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 12, 2016
Enrollment StartOct 1, 2012
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.0 years ago

Interventions

Peri-articular tranexamic aciddrug

750 mg of peri-articular TXA, prior to deflating the tourniquet and wound closure

Intravenous tranexamic aciddrug

750 mg of IV TXA, prior to deflating the tourniquet and wound closure